Highlights

Feb. 03 Medacta Group Posts Higher Preliminary FY25 Revenue MT
25-10-10 Berenberg Raises Medacta Price Target Amid Strong Earnings Momentum MT
25-09-08 Medacta Logs Higher H1 Profit, Revenue MT
25-09-08 Medacta Group SA Confirms Earnings Guidance for the Year 2025 CI
25-09-04 Medacta Group SA Reports Earnings Results for the Half Year Ended June 30, 2025 CI
25-07-31 Medacta Group Sa Revises Earnings Guidance for the Year 2025 CI
25-07-31 Medacta Group Books Higher H1 Preliminary Revenue MT
25-05-07 Medacta Group Sa Approves Distribution CI
25-03-25 Medacta Posts Higher FY24 Profit, Revenue MT
25-03-25 Medacta Group SA Provides Earnings Guidance for the Year 2025 CI
25-03-24 Medacta Group SA announces Annual dividend, payable on May 13, 2025 CI
25-03-24 Medacta Group SA Reports Earnings Results for the Full Year Ended December 31, 2024 CI
25-03-07 Anika Therapeutics Completes Divestiture of Parcus Medical to Medacta MT
25-03-07 Medacta Group Finalizes Purchase of Parcus Medical MT
25-03-06 Medacta Group SA acquired Parcus Medical, LLC from Anika Therapeutics, Inc.. CI
25-02-04 Medacta Group Logs Higher Preliminary FY24 Revenue MT
24-09-25 Swiss Market Index Advances Ahead of SNB's Rate Decision Day MT
24-09-25 Medacta Group Reports Growth in H1 Attributable Profit, Revenue MT
24-09-24 Medacta's Profitability at Risk Amid Expected Sales Slowdown in H1, Morgan Stanley Says MT
24-09-23 Medacta Group SA Reports Earnings Results for the Half Year Ended June 30, 2024 CI
24-08-30 Medacta Group, Think Surgical Partner in US for Robotic Total Knee Arthroplasty Solution MT
24-08-28 Medacta Group, Mighty Oak Medical Settle Patent Dispute via New License Deal MT
24-03-13 Medacta Group SA Proposes Distribution CI
24-03-13 Medacta Group SA Provides Earnings Guidance for the Year 2024 CI
24-03-13 Medacta Group Records Higher FY23 Attributable Profit, Revenue MT
No results for this search